Crescent Capital BDC, Inc. (FCRX) 股票分析

公司概述

Crescent Capital BDC, Inc. (FCRX) operates as a business development company with a primary focus on private equity, buyouts, and loan fund strategies within the middle market. The entity specializes in direct investment activities targeting opportunities located in the United States, distinguishing its operational model through a direct approach to capital allocation. While specific sector and industry classifications are not explicitly defined in the available data, the company's business description situates it within the broader financial services landscape focused on debt and equity investments for middle-market entities. The company's scale is characterized by a trailing twelve-month revenue of $167.28 million and a market capitalization that is not currently disclosed in the provided facts. Additionally, the number of employees employed by the organization is not listed in the available information. These financial figures, particularly the substantial annual revenue, indicate a mature operational footprint capable of generating significant income from its lending and investment portfolio, while the undisclosed market cap suggests a valuation that may be derived from other metrics such as price-to-book ratios rather than standard market capitalization calculations. The absence of employee count data limits the ability to gauge headcount efficiency, but the revenue generation implies a robust asset base supporting its investment mandate.

财务健康

The company reported a revenue of $167.28 million for the trailing twelve months, generating a net income of $34.51 million, while EBITDA figures are not available in the current dataset. The significant gap between the revenue of $167.28 million and the net income of $34.51 million reveals a cost structure where operating expenses, interest payments, and other deductions consume approximately 79.4% of total revenue before arriving at the bottom line. Free cash flow stands at $48.25 million, which provides the company with substantial financial flexibility to service its obligations, return capital, or pursue new investment opportunities without relying solely on external financing. Profitability analysis shows a gross margin of 100.0%, an operating margin of 75.4%, and a profit margin of 20.6%, indicating that the company incurs no direct costs of goods sold typical of product-based businesses and maintains strong efficiency in converting operating revenue to profit. Regarding liquidity and leverage, the company holds $5.04 million in cash against a total debt load of $873.76 million, resulting in a debt-to-equity ratio of 123.76, which indicates a highly leveraged balance sheet typical of business development companies. The current ratio is 1.27, suggesting that the company possesses sufficient short-term assets to cover its short-term liabilities, though the margin is relatively narrow given the high leverage. Return on equity and return on assets both stand at 4.8%, metrics that reveal the efficiency with which management utilizes the capital invested by shareholders and the assets deployed to generate returns.

估值评估

Valuation metrics indicate a trailing P/E ratio of 176.06, while the forward P/E ratio is not available in the provided data. The absence of a forward P/E figure prevents a direct comparison regarding expected earnings trajectory, though the high trailing multiple suggests the market prices in significant future growth or stability that is not yet reflected in current earnings. The price-to-book ratio is 1.31, indicating that the company trades at a 31% premium over its book value, which may reflect the quality of its underlying loan assets or the value of its investment portfolio not fully captured on the balance sheet. Alternative valuation metrics such as price-to-sales and EV/EBITDA are not disclosed in the available facts, limiting the depth of comparative valuation analysis using these specific tools. The stock's price range over the last year spans from a 52-week low of $24.50 to a 52-week high of $25.24. Without the specific current share price to calculate the exact percentage deviation, the trading range indicates a stock with relatively low volatility within the past year. The beta value is 0.60, which means the stock's price volatility is historically 40% lower than the broader market, suggesting it acts as a defensive position relative to the overall equity market performance.

Growth & Income

Growth metrics show a revenue growth rate of -12.1% year-over-year and an earnings growth rate of -14.9% year-over-year. Earnings are declining at a faster rate than revenue, as indicated by the earnings contraction being more severe than the revenue contraction, which implies that cost pressures or margin compression are intensifying faster than top-line declines. As a business development company, the dividend yield and payout ratio are not available in the provided facts, precluding an assessment of dividend sustainability or payout history. Consequently, the company appears to reinvest its earnings or utilize free cash flow for growth initiatives rather than distributing a significant portion of profits to shareholders in the form of dividends. The overall growth and income profile is currently characterized by double-digit contractions in both revenue and earnings, coupled with a lack of available dividend data, presenting a scenario where capital retention for balance sheet management or strategic redeployment is likely prioritized over income generation for shareholders.